// App-Quantinova.ai

2262 : Fondaparinux Versus Argatroban and Danaparoid for the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia: A Propensity Score Analysis.

Researchers

Presenter

  • Majed Alahmadi

Principal Investigators

  • Sonja Sawh

  • Michael J. Kovacs

  • Alejandro Lazo-Langner

Medical Centers

  • University of Western Ontario, London Health Sciences Centre, London,Canada

  • Pharmacy Services, London Health Sciences Centre,

  • Department of Hematology, London Health Sciences Centre - Victoria Hospital, London, ON, Canada

  • London Health Sciences Center, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Creatinine

Drug/Treatment

  • Fondaparinux sodium

  • Argatroban

  • Orgaran

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved